Literature DB >> 19520289

Positron emission tomography imaging of (2R,3R)-5-[(18)F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter.

Michael R Kilbourn1, Brian Hockley, Lihsueh Lee, Phillip Sherman, Carole Quesada, Kirk A Frey, Robert A Koeppe.   

Abstract

INTRODUCTION: The regional brain distribution of (2R,3R)-5-[(18)F]fluoroethoxy-benzovesamicol ((-)-[(18)F]FEOBV), a radioligand for the vesicular acetylcholine transporter (VAChT), was examined in vivo in mice, rats and rhesus monkeys.
METHODS: Regional brain distributions of (-)-[(18)F]FEOBV in mice were determined using ex vivo dissection. MicroPET imaging was used to determine the regional brain pharmacokinetics of the radioligand in rat and rhesus monkey brains.
RESULTS: In all three species, clear heterogeneous regional brain distributions were obtained, with the rank order of brain tissues (striatum>thalamus>cortex>cerebellum) consistent with the distribution of cholinergic nerve terminals containing the VAChT.
CONCLUSIONS: (-)-[(18)F]FEOBV remains a viable candidate for further development as an in vivo imaging agent for positron emission tomography (PET) studies of the VAChT in the human brain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520289      PMCID: PMC2696062          DOI: 10.1016/j.nucmedbio.2009.02.007

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  11 in total

Review 1.  In vivo imaging of the vesicular acetylcholine transporter and the vesicular monoamine transporter.

Authors:  S M Efange
Journal:  FASEB J       Date:  2000-12       Impact factor: 5.191

2.  Positron emission tomographic studies of central cholinergic nerve terminals.

Authors:  L Widén; L Eriksson; M Ingvar; S M Parsons; G A Rogers; S Stone-Elander
Journal:  Neurosci Lett       Date:  1992-02-17       Impact factor: 3.046

3.  Mouse brain distribution of a carbon-11 labeled vesamicol derivative: presynaptic marker of cholinergic neurons.

Authors:  M R Kilbourn; Y W Jung; M S Haka; D L Gildersleeve; D E Kuhl; D M Wieland
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

4.  Diminished striatal [123I]iodobenzovesamicol binding in idiopathic cervical dystonia.

Authors:  Roger L Albin; Donna Cross; Wayne T Cornblath; John A Wald; Kristine Wernette; Kirk A Frey; Satoshi Minoshima
Journal:  Ann Neurol       Date:  2003-04       Impact factor: 10.422

5.  Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA.

Authors:  S Gilman; R D Chervin; R A Koeppe; F B Consens; R Little; H An; L Junck; M Heumann
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

6.  [18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses.

Authors:  G K Mulholland; D M Wieland; M R Kilbourn; K A Frey; P S Sherman; J E Carey; D E Kuhl
Journal:  Synapse       Date:  1998-11       Impact factor: 2.562

7.  Ex vivo and in vivo evaluation of (2R,3R)-5-[(18)F]-fluoroethoxy- and fluoropropoxy-benzovesamicol, as PET radioligands for the vesicular acetylcholine transporter.

Authors:  Nicolas Giboureau; Patrick Emond; Roger R Fulton; David J Henderson; Sylvie Chalon; Lucette Garreau; Peter Roselt; Stefan Eberl; Sylvie Mavel; Sylvie Bodard; Michael J Fulham; Denis Guilloteau; Michael Kassiou
Journal:  Synapse       Date:  2007-12       Impact factor: 2.562

8.  In vivo SPECT imaging of vesicular acetylcholine transporter using [(123)I]-IBVM in early Alzheimer's disease.

Authors:  J Mazère; C Prunier; O Barret; M Guyot; C Hommet; D Guilloteau; J F Dartigues; S Auriacombe; C Fabrigoule; M Allard
Journal:  Neuroimage       Date:  2007-12-03       Impact factor: 6.556

9.  In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease.

Authors:  D E Kuhl; S Minoshima; J A Fessler; K A Frey; N L Foster; E P Ficaro; D M Wieland; R A Koeppe
Journal:  Ann Neurol       Date:  1996-09       Impact factor: 10.422

10.  The potential of (-)-o-[11C]methylvesamicol for diagnosing cholinergic deficit dementia.

Authors:  Kazuhiro Shiba; Shingo Nishiyama; Hideo Tsukada; Kiichi Ishiwata; Kazunori Kawamura; Kazuma Ogawa; Hirofumi Mori
Journal:  Synapse       Date:  2009-02       Impact factor: 2.562

View more
  20 in total

1.  Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates.

Authors:  Hongjun Jin; Xiang Zhang; Xuyi Yue; Hui Liu; Junfeng Li; Hao Yang; Hubert Flores; Yi Su; Stanley M Parsons; Joel S Perlmutter; Zhude Tu
Journal:  Nucl Med Biol       Date:  2015-11-07       Impact factor: 2.408

2.  Kinetic modeling of [18 F]VAT, a novel radioligand for positron emission tomography imaging vesicular acetylcholine transporter in non-human primate brain.

Authors:  Hongjun Jin; Xuyi Yue; Hui Liu; Junbin Han; Hubert Flores; Yi Su; Stanley M Parsons; Joel S Perlmutter; Zhude Tu
Journal:  J Neurochem       Date:  2018-03-25       Impact factor: 5.372

3.  Heteroaromatic and aniline derivatives of piperidines as potent ligands for vesicular acetylcholine transporter.

Authors:  Junfeng Li; Xiang Zhang; Zhanbin Zhang; Prashanth K Padakanti; Hongjun Jin; Jinquan Cui; Aixiao Li; Dexing Zeng; Nigam P Rath; Hubert Flores; Joel S Perlmutter; Stanley M Parsons; Zhude Tu
Journal:  J Med Chem       Date:  2013-07-18       Impact factor: 7.446

4.  Synthesis and in vitro biological evaluation of carbonyl group-containing inhibitors of vesicular acetylcholine transporter.

Authors:  Simon M N Efange; Anil B Khare; Krystyna von Hohenberg; Robert H Mach; Stanley M Parsons; Zhude Tu
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

5.  In vitro and in vivo characterization of two C-11-labeled pet tracers for vesicular acetylcholine transporter.

Authors:  Prashanth K Padakanti; Xiang Zhang; Hongjun Jin; Jinquan Cui; Ruike Wang; Junfeng Li; Hubert P Flores; Stanley M Parsons; Joel S Perlmutter; Zhude Tu
Journal:  Mol Imaging Biol       Date:  2014-12       Impact factor: 3.488

6.  Highlighting the Versatility of the Tracerlab Synthesis Modules. Part 1: Fully Automated Production of [F]Labelled Radiopharmaceuticals using a Tracerlab FX(FN).

Authors:  Xia Shao; Raphaël Hoareau; Brian G Hockley; Louis J M Tluczek; Bradford D Henderson; Henry C Padgett; Peter J H Scott
Journal:  J Labelled Comp Radiopharm       Date:  2011-05-30       Impact factor: 1.921

7.  Synthesis and biological characterization of a promising F-18 PET tracer for vesicular acetylcholine transporter.

Authors:  Zhude Tu; Xiang Zhang; Hongjun Jin; Xuyi Yue; Prashanth K Padakanti; Lihai Yu; Hui Liu; Hubert P Flores; Kota Kaneshige; Stanley M Parsons; Joel S Perlmutter
Journal:  Bioorg Med Chem       Date:  2015-06-05       Impact factor: 3.641

8.  MicroPET imaging of ketamine-induced neuronal apoptosis with radiolabeled DFNSH.

Authors:  X Zhang; M G Paule; G D Newport; N Sadovova; M S Berridge; S M Apana; G Kabalka; W Miao; W Slikker; Cheng Wang
Journal:  J Neural Transm (Vienna)       Date:  2010-10-21       Impact factor: 3.575

9.  Automated production of [¹⁸F]VAT suitable for clinical PET study of vesicular acetylcholine transporter.

Authors:  Xuyi Yue; Christopher Bognar; Xiang Zhang; Gregory G Gaehle; Stephen M Moerlein; Joel S Perlmutter; Zhude Tu
Journal:  Appl Radiat Isot       Date:  2015-09-10       Impact factor: 1.513

10.  Syntheses and radiosyntheses of two carbon-11 labeled potent and selective radioligands for imaging vesicular acetylcholine transporter.

Authors:  Prashanth K Padakanti; Xiang Zhang; Junfeng Li; Stanley M Parsons; Joel S Perlmutter; Zhude Tu
Journal:  Mol Imaging Biol       Date:  2014-12       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.